874903-66-9Relevant academic research and scientific papers
Orally active purine-based inhibitors of the heat shock protein 90
Biamonte, Marco A.,Shi, Jiandong,Hong, Kevin,Hurst, David C.,Zhang, Lin,Fan, Junhua,Busch, David J.,Karjian, Patricia L.,Maldonado, Angelica A.,Sensintaffar, John L.,Yang, Yong-Ching,Kamal, Adeela,Lough, Rachel E.,Lundgren, Karen,Burrows, Francis J.,Timony, Gregg A.,Boehm, Marcus F.,Kasibhatla, Srinivas R.
, p. 817 - 828 (2007/10/03)
Orally active Hsp90 inhibitors are of interest as potential chemotherapeutic agents. Recently, fully synthetic 8-benzyladenines and 8-sulfanyladenines such as 4 were disclosed as Hsp90 inhibitors, but these compounds are not water soluble and consequently
Adenine derived inhibitors of the molecular chaperone HSP90 - SAR explained through multiple X-ray structures
Dymock, Brian,Barril, Xavier,Beswick, Mandy,Collier, Adam,Davies, Nicholas,Drysdale, Martin,Fink, Alexandra,Fromont, Christophe,Hubbard, Roderick E.,Massey, Andrew,Surgenor, Allan,Wright, Lisa
, p. 325 - 328 (2007/10/03)
Multiple co-crystal structures of an adenine-based series of inhibitors bound to the molecular chaperone Hsp90 have been determined. These structures explain the observed SAR for previously described compounds and new compounds, which possess up to 8-fold
